James Auerbach, MD
Dermatology · Santa Fe, NMNPI 1154426427
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 24 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by AbbVie at 37.8% of the total. 2025 is the largest year on record at $247, 2.7 times the $92 reported in 2019. That places this record below the midpoint for dermatology clinicians in NM, where the typical reported total is $1,036.
Across 24 payments — averaging $18.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$169
- Johnson & Johnson$51
- Biofrontera Inc.$43
- Novartis$32
- Organon$31
- LEO Pharma Inc.$29
- plus $92 from 5 others
What the payments were for
- Food & beverage$446100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 9 | $169 |
| Johnson & Johnson | 2 | $51 |
| Biofrontera Inc. | 2 | $43 |
| Novartis | 2 | $32 |
| Organon | 2 | $31 |
| LEO Pharma Inc. | 1 | $29 |
| Galderma Laboratories, L.p. | 2 | $26 |
| Kyowa Kirin, Inc. | 1 | $19 |
| Sun Pharmaceutical Industries Inc. | 1 | $19 |
| UCB, Inc. | 1 | $14 |
| Amgen | 1 | $14 |
How this compares
$446 in reported general payments places this provider in the 40th percentile of 52 dermatology providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira PenAdalimumab | 11 | $73,560 |
| Dupixent PenDupilumab | 18 | $62,906 |
| Tretinoin | 59 | $5,435 |
| Ketoconazole | 284 | $5,201 |
| Doxycycline Hyclate | 115 | $4,056 |
| Clobetasol Propionate | 89 | $2,670 |
| Famciclovir | 52 | $2,108 |
| Spironolactone | 64 | $2,076 |
| Triamcinolone Acetonide | 163 | $2,062 |
| Metronidazole | 29 | $1,569 |
| Hydrocortisone | 117 | $789 |
| Dutasteride | 11 | $490 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 12 | $162 |
| Mupirocin | 11 | $87 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Santa Fe
- John BowdenSanta Fe$3K
- Trisha PatelSanta Fe$3K
- Allison LeglerSanta Fe$2K
- Brenda SchneiderSanta Fe$236
- Ronald RovnerSanta Fe$192
- Diane ReisingerSanta Fe$0
- Andrew OndoLas Cruces$215K
- John DurkinAlbuquerque$153K
- Barbara EinhornAlbuquerque$15K
- Carol PurcellAlbuquerque$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.